| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/01/2010 | CA2747055A1 Substituted benzimidazole derivatives as protein kinase inhibitors |
| 07/01/2010 | CA2746085A1 Enzastaurin for the treatment of cancer |
| 07/01/2010 | CA2728118A1 Compounds for treatment of cancer |
| 06/30/2010 | EP2202293A2 New mutactimycin and aldgamycin active compounds and the use thereof in therapy |
| 06/30/2010 | EP2202240A1 Compound |
| 06/30/2010 | EP2202237A1 Hydrosoluble [6)-O-alpha-d-glcp-(1->]n-6-o-bêta-d-glcp-(1->-phenllic derivatives with dermocosmetic, nutritional and therapeutic applications, and compositions containing said water soluble compounds |
| 06/30/2010 | EP2202235A1 Bis(trimethylsilyl)phenyl compound or salt thereof, and use thereof |
| 06/30/2010 | EP2202232A1 1,2,4-oxadiazole derivatives and their therapeutic use |
| 06/30/2010 | EP2202231A1 2,3-dihydroiminoisoindole derivative |
| 06/30/2010 | EP2201957A1 Anti-aids, anti-tumour, immune-system-stimulating herbal composition and production method therefor |
| 06/30/2010 | EP2201947A2 Use of SAHA for treating mesothelioma |
| 06/30/2010 | EP2201897A2 Tumor targeted photodiagnostic-phototherapeutic agents |
| 06/30/2010 | EP2201840A1 Inhibitors of Bruton's Tyrosine Kinase |
| 06/30/2010 | EP2201562A2 Insulin-like growth factor binding protein 7 for treatment of cancer |
| 06/30/2010 | EP2201033A2 Methods of treating cancer using notch pathway inhibitors |
| 06/30/2010 | EP2201026A1 Novel p2x7 epitopes |
| 06/30/2010 | EP2201018A2 Solid forms comprising n-(5-tert-butyl-isoxazol-3-yl)-n'-{4-ý7-(2-morpholin-4-yl-ethoxy)imidazoý2,1-b¨ý1,3¨benzothiazol-2-yl¨phenyl}urea, compositions thereof, and uses therewith |
| 06/30/2010 | EP2201017A1 Artemisinin derivatives for the treatment of melanoma |
| 06/30/2010 | EP2201012A1 Pyrrolo [2, 3 -d] pyrimidin derivatives as protein kinase b inhibitors |
| 06/30/2010 | EP2201007A1 Cannabinoid receptor ligands |
| 06/30/2010 | EP2201001A1 Novel imidazole derivatives |
| 06/30/2010 | EP2201000A1 Novel imidazole derivatives |
| 06/30/2010 | EP2200997A1 Synthesis of deuterated catechols and benzoýd¨ý1,3¨dioxoles and derivatives thereof |
| 06/30/2010 | EP2200994A1 Condensed compounds with activity at estrogen receptors |
| 06/30/2010 | EP2200967A2 New no-donor aspirin derivatives |
| 06/30/2010 | EP2200700A1 Novel antibodies |
| 06/30/2010 | EP2200659A2 Use of lanthanide-based nanoparticles as radiosensitizing agents |
| 06/30/2010 | EP2200653A2 Mitochondria-targeted anti-tumour agents |
| 06/30/2010 | EP2200634A1 Targeted interferon demonstrates potent apoptotic and anti-tumor activities |
| 06/30/2010 | EP2200632A2 The use of a non-glycanated polypeptide for treating a cancer |
| 06/30/2010 | EP2200615A1 A3 adenosine receptor antagonists |
| 06/30/2010 | EP2200612A1 Inhibitors of janus kinases |
| 06/30/2010 | EP2200584A2 Formulation containing cyclin-dependent kinase inhibiting compound and method of treating tumors using the same |
| 06/30/2010 | EP2200437A1 Tricyclic compounds having cytostatic and/or cytotoxic activity and methods of use thereof |
| 06/30/2010 | EP2200431A1 Novel compositions and methods for cancer treatment |
| 06/30/2010 | EP1891008B1 Oxindoles as kinase inhibitors |
| 06/30/2010 | EP1841763B1 5-heteroaryl thiazoles and their use as pi3k inhibitors |
| 06/30/2010 | EP1682552B1 Tocopherol-modified therapeutic drug compounds |
| 06/30/2010 | EP1578799B1 Antibodies directed to tumor necrosis factor and uses thereof |
| 06/30/2010 | EP1516881B1 Composition and method for modulating dendritic Cell-T cell interaction |
| 06/30/2010 | EP1411927B1 Method for the preparation of selectively-substituted corroles and new substituted corroles |
| 06/30/2010 | EP1368323B1 Pyrimidine matrix metalloproteinase inhibitors |
| 06/30/2010 | EP1332366B1 Methods for the Assessment of Cellular Proliferative Disorders |
| 06/30/2010 | EP1284727B1 Intracorporeal medicaments for photodynamic treatment of disease |
| 06/30/2010 | EP1278735B1 2,4-di(hetero-)arylamino(-oxy)-5-substituted pyrimidines as antineoplastic agents |
| 06/30/2010 | CN1966082B Genetic medicine for preventing and treating cancer of colon and rectum, preparation process and use thereof |
| 06/30/2010 | CN1781479B Chinese small iris seed agent dispersion system and its preparing method |
| 06/30/2010 | CN1533276B Use of thiazole derivatives for preparing medicine for protecting mitochondria |
| 06/30/2010 | CN101765600A pyrazolopyrimidinone kinase inhibitor |
| 06/30/2010 | CN101765597A Pyrimidine derivatives as inhibitors of phosphatidylinositol-3-kinase |
| 06/30/2010 | CN101765596A Inhibitors of hypoxia inducible factor (HIF) useful for treating hyper-proliferative disorders and diseases associated with angiogenesis |
| 06/30/2010 | CN101765591A Pyrimidine derivatives useful for the treatment of inflammatory or allergic conditions |
| 06/30/2010 | CN101765434A Composition of tumour-associated peptides and related anti-cancer vaccine |
| 06/30/2010 | CN101760475A Recombinant retroviral vector |
| 06/30/2010 | CN101760474A EMX2 adenovirus vector and application thereof |
| 06/30/2010 | CN101759882A Sephadex magnetic composite particles and preparation and use thereof |
| 06/30/2010 | CN101759805A Long-acting thymosin alpha1-polyethylene glycol modifiers |
| 06/30/2010 | CN101759804A Anti-human thyroglobulin monoclonal antibody and application thereof |
| 06/30/2010 | CN101759801A Separation and purification method of novel soybean trypsin inhibitor |
| 06/30/2010 | CN101759779A Active spider polypeptide, preparation method and application thereof |
| 06/30/2010 | CN101759763A Triptolide derivative, and preparation method and application thereof |
| 06/30/2010 | CN101759752A Ginsenoside Rg 1 containing ginsenoside Rg 2 impurity |
| 06/30/2010 | CN101759751A Ginsenoside Rg 1 containing ginsenoside Re impurity |
| 06/30/2010 | CN101759750A Ginsenoside Rg 1 containing ginsenoside Rh 1 and ginsenoside F1 impurities |
| 06/30/2010 | CN101759749A Ginsenoside Rg 1 containing ginsenoside Rf and/or pseudo-ginsenoside F11 impurity |
| 06/30/2010 | CN101759720A Acyclic nucleoside phosphonate compounds or pharmaceutically acceptable salts thereof, preparation method, application, intermediate compounds thereof, and medicinal composition containing same |
| 06/30/2010 | CN101759715A 5-chloro-salicyloyl hydrazine tributyltin chloride coordination compound as well as preparation method and application thereof |
| 06/30/2010 | CN101759707A Heterocyclic ring substituent norcantharidin derivative and synthesis method and application thereof |
| 06/30/2010 | CN101759699A Pyrro-perhydroazepinone compound and application thereof in preparing medicaments for treating tumors |
| 06/30/2010 | CN101759695A Thiazole derivative containing pyrazole ring and preparation method and application thereof |
| 06/30/2010 | CN101759694A 2-(1, 3-disubstituted phenyl-4-pyrazolyl) benzothiazole compound as well as preparation method and application thereof |
| 06/30/2010 | CN101759692A Preparation and use of thiocarbonyl compound |
| 06/30/2010 | CN101759683A Preparation method of hydrindene amide compound, medical composition comprising hydrindene amide compound and application thereof as protein kinase inhibitor |
| 06/30/2010 | CN101759675A Method for preparing active sesquiterpenes with functions of cancer resistance and bacterium inhibition from ligularia fischeri |
| 06/30/2010 | CN101759672A Salvianolic acid B in radix salviae miltiorrhizae |
| 06/30/2010 | CN101759654A 4-quinazolinone-6-methylamino dithiocarbamate as well as medical composition and application thereof |
| 06/30/2010 | CN101759644A Crystalline form III of Lonidamine and preparation method thereof and composition containing same |
| 06/30/2010 | CN101759544A Novel chalcone compound and preparation method and application thereof |
| 06/30/2010 | CN101757644A Structure of radioactive micro balls and preparation method |
| 06/30/2010 | CN101757640A Preparation of clathrate compound containing isoflavone and cyclodextrin of chickpea |
| 06/30/2010 | CN101757633A Preparation method of composite injection for chemotherapy of colon cancer |
| 06/30/2010 | CN101757626A Pharmaceutical composition containing insulin-like growth factor-I receptor inhibitor and histon deacetylase (HDAC) inhibitor and application thereof |
| 06/30/2010 | CN101757608A Application of phycobiliprotein in preparation of photosensitizer for treating oral and pharyngeal cancer cell by using iodine-tungsten lamp |
| 06/30/2010 | CN101757602A Traditional Chinese medicine composition for treating cardiac carcinoma and preparation method thereof |
| 06/30/2010 | CN101757598A Traditional Chinese medicine composition for treating advanced malignant liver tumor symptoms and preparation method thereof |
| 06/30/2010 | CN101757571A Externally-applied traditional Chinese medicine composition for treating brain tumor and preparation method thereof |
| 06/30/2010 | CN101757567A Traditional Chinese medicine composition for treating rectal cancer and preparation method thereof |
| 06/30/2010 | CN101757566A Traditional Chinese medicine composition for treating colon cancer and preparation method thereof |
| 06/30/2010 | CN101757562A Traditional Chinese medicine composition for treating mid-term malignant liver tumor symptoms and preparation method thereof |
| 06/30/2010 | CN101757560A Medicament for treating liver cancer and preparation method thereof |
| 06/30/2010 | CN101757558A Chinese herbal medicine preparation for treating malignant lymphatic tumor and preparation method thereof |
| 06/30/2010 | CN101757511A Medicine composition for treating acute and chronic neutrophilic leukemia and preparation method thereof |
| 06/30/2010 | CN101757445A Chinese herbal preparation for treating nasopharyngeal carcinoma |
| 06/30/2010 | CN101757425A Method for curing lung cancer by using tonifying Qi reinforcing lungs prescription |
| 06/30/2010 | CN101757338A Medicament for treating digestive tract tumor and preparation method thereof |
| 06/30/2010 | CN101757302A Medicament composition for treating leukemia |
| 06/30/2010 | CN101757249A Ejiao Eling paste |
| 06/30/2010 | CN101757243A Traditional Chinese medicine for treating leukemia |
| 06/30/2010 | CN101757185A Extraction of novel natural pigment and preparation method of inclusion compound thereof |
| 06/30/2010 | CN101757128A Extraction and preparation method of total phenol of compound abnormal savda munziq |